Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2016, Article ID 6845213, 6 pages
http://dx.doi.org/10.1155/2016/6845213
Research Article

Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer

1Department of Gynecology, Campus Virchow Klinikum, Charité Universitätsmedizin Berlin, Berlin, Germany
2Department of Nephrology and Intensive Care Medicine, Charité Universtätsmedizin Berlin, Berlin, Germany
3CellTrend, Luckenwalde, Germany
4Experimental and Clinical Research Center, Berlin, Germany

Received 25 April 2016; Accepted 3 August 2016

Academic Editor: Giovanni Tuccari

Copyright © 2016 Katrin Kreienbring et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Burges and B. Schmalfeldt, “Ovarian cancer: diagnosis and treatment,” Deutsches Ärzteblatt International, vol. 108, no. 38, pp. 635–641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Rizzuto, C. Stavraka, J. Chatterjee et al., “Risk of ovarian cancer relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer,” International Journal of Gynecological Cancer, vol. 25, no. 3, pp. 416–422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. T. G. Clark, M. E. Stewart, D. G. Altman, H. Gabra, and J. F. Smyth, “A prognostic model for ovarian cancer,” British Journal of Cancer, vol. 85, no. 7, pp. 944–952, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Sehouli, R. Richter, E. I. Braicu et al., “Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? a systematic analysis of 240 consecutive patients,” Journal of Surgical Oncology, vol. 102, no. 6, pp. 656–662, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Sehouli, K. Savvatis, E.-I. Braicu, S.-C. Schmidt, W. Lichtenegger, and C. Fotopoulou, “Primary versus interval debulking surgery in advanced ovarian cancer: results from a systematic single-center analysis,” International Journal of Gynecological Cancer, vol. 20, no. 8, pp. 1331–1340, 2010. View at Google Scholar · View at Scopus
  6. J. Ludwig, S. Kerscher, U. Brandt et al., “Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules,” The Journal of Biological Chemistry, vol. 273, no. 18, pp. 10939–10947, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Nguyen, F. Delarue, C. Burcklé, L. Bouzhir, T. Giller, and J.-D. Sraer, “Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin,” The Journal of Clinical Investigation, vol. 109, no. 11, pp. 1417–1427, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Bernhard, K. Seidel, J. Schmitz et al., “The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling,” Biochemical Pharmacology, vol. 84, no. 12, pp. 1643–1650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Barker and H. Clevers, “Mining the Wnt pathway for cancer therapeutics,” Nature Reviews Drug Discovery, vol. 5, no. 12, pp. 997–1014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Funke-Kaiser, F. S. Zollmann, J. H. Schefe, and T. Unger, “Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage,” Hypertension Research, vol. 33, no. 2, pp. 98–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Ino, K. Shibata, H. Kajiyama et al., “Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival,” British Journal of Cancer, vol. 94, no. 4, pp. 552–560, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Beyazit, S. Ayhan, H. T. Celik, and T. Gungor, “Assessment of serum angiotensin-converting enzyme in patients with epithelial ovarian cancer,” Archives of Gynecology and Obstetrics, vol. 292, no. 2, pp. 415–420, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Suganuma, K. Ino, K. Shibata et al., “Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockadetherapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination,” Clinical Cancer Research, vol. 11, no. 7, pp. 2686–2694, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. R. Lumbers, Y. Wang, S. J. Delforce et al., “Decidualisation of human endometrial stromal cells is associated with increased expression and secretion of prorenin,” Reproductive Biology and Endocrinology, vol. 13, no. 1, article 129, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Ando, K. Furugori, D. Shibata, T. Harata, Y. Murata, and S. Mizutani, “Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series,” Human Reproduction, vol. 18, no. 6, pp. 1219–1222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Ando, T. Nagasaka, M. Nomura et al., “Premenstrual disappearance of aminopeptidase A in endometrial stromal cells around endometrial spiral arteries/arterioles during the decidual change,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2303–2309, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Herr, I. Bekes, and C. Wulff, “Local renin-angiotensin system in the reproductive system,” Frontiers in Endocrinology, vol. 4, article 150, 2013. View at Publisher · View at Google Scholar
  18. F. Deshayes and C. Nahmias, “Angiotensin receptors: a new role in cancer?” Trends in Endocrinology and Metabolism, vol. 16, no. 7, pp. 293–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Pupilli, L. Lasagni, P. Romagnani et al., “Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells,” Journal of the American Society of Nephrology, vol. 10, no. 2, pp. 245–255, 1999. View at Google Scholar · View at Scopus
  20. R. D. Machado, R. A. Santos, and S. P. Andrade, “Opposing actions of angiotensins on angiogenesis,” Life Sciences, vol. 66, no. 1, pp. 67–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. E. I. Ager, J. Neo, and C. Christophi, “The renin-angiotensin system and malignancy,” Carcinogenesis, vol. 29, no. 9, pp. 1675–1684, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. F. Lever, D. J. Hole, C. R. Gillis et al., “Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?” The Lancet, vol. 352, no. 9123, pp. 179–184, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. S. L. McDonald and A. Silver, “The opposing roles of Wnt-5a in cancer,” British Journal of Cancer, vol. 101, no. 2, pp. 209–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Dai, J. M. Teodoridis, C. Zeller et al., “Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival,” Clinical Cancer Research, vol. 17, no. 12, pp. 4052–4062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Huang and H. M. Siragy, “Glucose promotes the production of interleukine-1β and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression,” Endocrinology, vol. 150, no. 12, pp. 5557–5565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Zhang, N. A. Noble, W. A. Border, R. T. Owens, and Y. Huang, “Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells,” American Journal of Physiology—Endocrinology and Metabolism, vol. 295, no. 4, pp. E810–E819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Xie, Z. Peng, M. Shi, M. Ji, H. Guo, and H. Shi, “Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin resistant ovarian cancer,” Molecular Medicine Reports, vol. 10, no. 5, pp. 2346–2350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Nguyen, A. Blanchard, E. Curis et al., “Plasma soluble (Pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity,” Hypertension, vol. 63, no. 2, pp. 297–302, 2014. View at Publisher · View at Google Scholar · View at Scopus